Abstract
It has been widely assumed that bone metabolism is controlled mostly by the local environment and does not affect the metabolism of other tissues. In other words, bone was thought to constitute an independent domain from the rest of the body. However, the discovery of neuronal control of bone mass by leptin has shed light on a novel pathway that controls bone metabolism [32]. Furthermore, the recent discovery that osteocalcin modified by OST-PTP regulates glucose metabolism opened a new domain linked to skeletal biology [39]. These unexpected relationships are an outgrowth from the wealth of genetically modified mouse models. Most of these pathways are still far from being fully explored, but the identification of a network between bone and other organs has attracted much attention from basic and clinical scientists.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahima RS, Flier JS (2000) Leptin. Annu Rev Physiol 62:413-437
Ahima RS, Osei SY (2004) Leptin signaling. Physiol Behav 81:223-241
Ahn JD, Dubern B, Lubrano-Berthelier C, Clement K, Karsenty G (2006) Cart overexpression is the only identifiable cause of high bone mass in melanocortin 4 receptor deficiency. Endocrinology 147:3196-3202
Asnicar MA, Smith DP, Yang DD, Heiman ML, Fox N, Chen YF et al (2001) Absence of cocaine- and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet. Endocrinology 142:4394-4400
Baldock PA, Allison SJ, Lundberg P, Lee NJ, Slack K, Lin EJ et al (2007) Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis. J Biol Chem 282:19092-19102
Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, Gardiner EM et al (2002) Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 109:915-921
Bonnet N, Laroche N, Vico L, Dolleans E, Benhamou CL, Courteix D (2006) Dose effects of propranolol on cancellous and cortical bone in ovariectomized adult rats. J Pharmacol Exp Ther 318:1118-1127
Bray GA, York DA (1998) The MONA LISA hypothesis in the time of leptin. Recent Prog Horm Res 53:95-117
Brighton PJ, Szekeres PG, Willars GB (2004) Neuromedin U and its receptors: structure, function, and physiological roles. Pharmacol Rev 56:231-248
Cock TA, Back J, Elefteriou F, Karsenty G, Kastner P, Chan S et al (2004) Enhanced bone formation in lipodystrophic PPARgamma(hyp/hyp) mice relocates haematopoiesis to the spleen. EMBO Rep 5:1007-1012
Cone RD (2006) Studies on the physiological functions of the melanocortin system. Endocr Rev 27:736-749
Cornish J, Callon KE, Bava U, Lin C, Naot D, Hill BL et al (2002) Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 175:405-415
Dacquin R, Mee PJ, Kawaguchi J, Olmsted-Davis EA, Gallagher JA, Nichols J et al (2004) Knock-in of nuclear localised beta-galactosidase reveals that the tyrosine phosphatase Ptprv is specifically expressed in cells of the bone collar. Dev Dyn 229:826-834
Douglass J, McKinzie AA, Couceyro P (1995) PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci 15:2471-2481
Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT et al (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197-207
Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C et al (1996) Increased bone formation in osteocalcin-deficient mice. Nature 382:448-452
Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X et al (2005) Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434:514-520
Elefteriou F, Takeda S, Ebihara K, Magre J, Patano N, Kim CA et al (2004) Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci U S A 101:3258-3263
Elefteriou F, Takeda S, Liu X, Armstrong D, Karsenty G (2003) Monosodium glutamate-sensitive hypothalamic neurons contribute to the control of bone mass. Endocrinology 144:3842-3847
Elias CF, Lee C, Kelly J, Aschkenasi C, Ahima RS, Couceyro PR et al (1998) Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron 21:1375-1385
Ferron M, Hinoi E, Karsenty G, Ducy P (2008) Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A 105:5266-5270
Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G (2005) The molecular clock mediates leptin-regulated bone formation. Cell 122:803-815
Goulding A, Taylor RW (1998) Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women. Calcif Tissue Int 63:456-458
Guerardel A, Tanko LB, Boutin P, Christiansen C, Froguel P (2006) Obesity susceptibility CART gene polymorphism contributes to bone remodeling in postmenopausal women. Osteoporos Int 17:156-157
Guidobono F, Pagani F, Sibilia V, Netti C, Lattuada N, Rapetti D et al (2006) Different skeletal regional response to continuous brain infusion of leptin in the rat. Peptides 27:1426-1433
Hainerova I, Torekov SS, Ek J, Finkova M, Borch-Johnsen K, Jorgensen T et al (2006) Association between neuromedin U gene variants and overweight and obesity. J Clin Endocrinol Metab 91:5057-5063
Hanada R, Nakazato M, Murakami N, Sakihara S, Yoshimatsu H, Toshinai K et al (2001) A role for neuromedin U in stress response. Biochem Biophys Res Commun 289:225-228
Hinoi E, Gao N, Jung DY, Yadav V, Yoshizawa T, Myers MG Jr et al (2008) The sympathetic tone mediates leptin’s inhibition of insulin secretion by modulating osteocalcin bioactivity. J Cell Biol 183:1235-1242
Imai J, Katagiri H, Yamada T, Ishigaki Y, Suzuki T, Kudo H et al (2008) Regulation of pancreatic beta cell mass by neuronal signals from the liver. Science 322:1250-1254
Kaga T, Inui A, Okita M, Asakawa A, Ueno N, Kasuga M et al (2001) Modest overexpression of neuropeptide Y in the brain leads to obesity after high-sucrose feeding. Diabetes 50:1206-1210
Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S et al (2009) Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 94:45-49
Karsenty G (2006) Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab 4:341-348
Kieffer TJ, Habener JF (2000) The adipoinsular axis: effects of leptin on pancreatic beta-cells. Am J Physiol Endocrinol Metab 278:E1-E14
Kindblom JM, Ohlsson C, Ljunggren O, Karlsson MK, Tivesten A, Smith U et al (2009) Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly swedish men. J Bone Miner Res 24(5):785-791
Kondo H, Nifuji A, Takeda S, Ezura Y, Rittling SR, Denhardt DT et al (2005) Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system. J Biol Chem 280:30192-30200
Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS et al (1998) Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393:72-76
Kurvers HA (1998) Reflex sympathetic dystrophy: facts and hypotheses. Vasc Med 3:207-214
Lee NK, Karsenty G (2008) Reciprocal regulation of bone and energy metabolism. Trends Endocrinol Metab 19:161-166
Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C et al (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130:456-469
Levasseur R, Sabatier JP, Potrel-Burgot C, Lecoq B, Creveuil C, Marcelli C (2003) Sympathetic nervous system as transmitter of mechanical loading in bone. Joint Bone Spine 70:515-519
Lian JB, Gundberg CM (1988) Osteocalcin. Biochemical considerations and clinical applications. Clin Orthop Relat Res (226):267-291
Lin S, Boey D, Herzog H (2004) NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 38:189-200
Lundberg P, Allison SJ, Lee NJ, Baldock PA, Brouard N, Rost S et al (2007) Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression. J Biol Chem 282:19082-19091
Martin A, de Vittoris R, David V, Moraes R, Begeot M, Lafage-Proust MH et al (2005) Leptin modulates both resorption and formation while preventing disuse-induced bone loss in tail-suspended female rats. Endocrinology 146:3652-3659
Martini G, Valenti R, Giovani S, Franci B, Campagna S, Nuti R (2001) Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women. Bone 28:113-117
Morberg CM, Tetens I, Black E, Toubro S, Soerensen TI, Pedersen O et al (2003) Leptin and bone mineral density: a cross-sectional study in obese and nonobese men. J Clin Endocrinol Metab 88:5795-5800
Nonogaki K (2000) New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 43:533-549
Pierroz DD, Bouxsein ML, Rizzoli R, Ferrari SL (2006) Combined treatment with a [beta]-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice. Bone 39:260-267
Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B (2009) Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 94:827-832
Pogoda P, Egermann M, Schnell JC, Priemel M, Schilling AF, Alini M et al (2006) Leptin inhibits bone formation not only in rodents, but also in sheep. J Bone Miner Res 21:1591-1599
Ruhl CE, Everhart JE (2002) Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res 17:1896-1903
Sainsbury A, Baldock PA, Schwarzer C, Ueno N, Enriquez RF, Couzens M et al (2003) Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice. Mol Cell Biol 23:5225-5233
Sakamoto N, Nishiike T, Iguchi H, Sakamoto K (2000) Possible effects of one week vitamin K (menaquinone-4) tablets intake on glucose tolerance in healthy young male volunteers with different descarboxy prothrombin levels. Clin Nutr 19:259-263
Sato M, Takeda N, Sarui H, Takami R, Takami K, Hayashi M et al (2001) Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men. J Clin Endocrinol Metab 86:5273-5276
Sato S, Hanada R, Kimura A, Abe T, Matsumoto T, Iwasaki M et al (2007) Central control of bone remodeling by neuromedin U. Nat Med 13:1234-1240
Shi Y, Yadav VK, Suda N, Liu XS, Guo XE, Myers MG Jr et al (2008) Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo. Proc Natl Acad Sci U S A 105:20529-20533
Takeda S (2008) Central control of bone remodelling. J Neuroendocrinol 20:802-807
Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL et al (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305-317
Tam J, Trembovler V, Di Marzo V, Petrosino S, Leo G, Alexandrovich A et al (2008) The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. FASEB J 22:285-294
Tartaglia LA (1997) The leptin receptor. J Biol Chem 272:6093-6096
Taylor WH, Khaleeli AA (2001) Coincident diabetes mellitus and primary hyperparathyroidism. Diabetes Metab Res Rev 17:175-180
Thomas T, Burguera B, Melton LJ III, Atkinson EJ, O’Fallon WM, Riggs BL et al (2001) Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women. Bone 29:114-120
Tsugawa N, Shiraki M, Suhara Y, Kamao M, Tanaka K, Okano T (2006) Vitamin K status of healthy Japanese women: age-related vitamin K requirement for gamma-carboxylation of osteocalcin. Am J Clin Nutr 83:380-386
Wiens M, Etminan M, Gill SS, Takkouche B (2006) Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies. J Intern Med 260:350-362
Yirmiya R, Goshen I, Bajayo A, Kreisel T, Feldman S, Tam J et al (2006) Depression induces bone loss through stimulation of the sympathetic nervous system. Proc Natl Acad Sci U S A 103:16876-16881
Zeng H, Gragerov A, Hohmann JG, Pavlova MN, Schimpf BA, Xu H et al (2006) Neuromedin U receptor 2-deficient mice display differential responses in sensory perception, stress, and feeding. Mol Cell Biol 26:9352-9363
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag London
About this chapter
Cite this chapter
Takeda, S. (2010). Interrelationship Between Bone and Other Tissues: Brain–Bone Axis and Bone-Adipo Axis. In: Bronner, F., Farach-Carson, M., Roach, H. (eds) Bone and Development. Topics in Bone Biology, vol 6. Springer, London. https://doi.org/10.1007/978-1-84882-822-3_16
Download citation
DOI: https://doi.org/10.1007/978-1-84882-822-3_16
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84882-821-6
Online ISBN: 978-1-84882-822-3
eBook Packages: MedicineMedicine (R0)